Ergoline derivatives and their use as somatostatin receptor antagonists

US6221870A · kind A · utility

Assignee

• Novartis AG · CH

Inventors

• Paul Pfaeffli · Oberwil, CH
• Peter Neumann · Wiesloch, DE
• Robert Swoboda · Oberwil, CH
• Peter Stutz · Wien, AT

Key dates

• Filing date: Nov 23, 1999
• Grant date: Apr 24, 2001
• Expiry date: Nov 23, 2019

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention provides compounds of formula I ##STR1## wherein R.sub.1 to R.sub.6 are as defined in the description, and a process for preparing them. The compounds of formula I are useful as pharmaceuticals.